Erin Kathleen Donnelly Michos is an American cardiologist. She is an associate professor of Medicine and Director of Women's Cardiovascular Health at Johns Hopkins School of Medicine. Michos is also an Associate Faculty of the Welch Center for Prevention, Epidemiology and Clinical Research at Johns Hopkins, and has a joint faculty appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Michos is an honorary fellow for the American Heart Association (FAHA), the American College of Cardiology (FACC), the American Society of Echocardiography (FASE), and the American Society of Preventive Cardiology (FASPC). During her tenure at Johns Hopkins, Michos has authored or co-authored over 300 manuscripts or book chapters published in peer-reviewed journals/textbooks.
Personal life and education
Michos earned her medical degree from Northwestern University and her Master's in public health (MHS) from Johns Hopkins Bloomberg School of Public Health. After earning her MHS, Michos became a clinical fellow at Johns Hopkins, where she co-authored an editorial with Dr. Roger S. Blumenthal titled Further improvements in CHD risk prediction for women. The editorial was published in the Journal of the American Medical Association and argued for improvements to be made to the criteria in assessing postmenopausal women's chances of developing cardiovascular diseases.
Michos is half Italian and married to a Greek husband. She competes in marathons during her time off.
Career
Michos joined the faculty at Johns Hopkins School of Medicine in 2007 as an instructor in their Division of Cardiology. She was promoted to assistant professor the following year. On July 1, 2008, Michos received the Clinician Scientist Award, which granted her $40,000, and American College of Cardiology Foundation/Pfizer Career Development Award, which granted her $65,000 over three years. In 2011, she was awarded a $1 million grant over four years from the National Institutes of Health National Institute of Neurologic Disorders and Stroke (NINDS) to evaluate the association of vitamin D with brain health outcomes. By May 2014, Michos was promoted to Associate professor.
Michos has participated in multiple national and international society guidelines and position statements including the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) guideline to update recommendations for the primary prevention of cardiovascular disease. She has also been a co-author on a 2017 AHA Scientific Statement on Meditation and Cardiovascular Risk Reduction, and the 2017 American Diabetes Association (ADA) position statement on Hypertension management.
Michos has been chosen to sit on the American College of Cardiology (ACC) Prevention Leadership Council and the Board of Directors for the American Society of Preventive Cardiology (ASPC). She also became an associate editor on the journal Circulation and for the American Journal of Preventive Cardiology (AJPC). She is an honorary fellow for the American Heart Association (FAHA), the American College of Cardiology (FACC), the American Society of Echocardiography (FASE), and the American Society of Preventive Cardiology (FASPC).
Research
As an assistant professor, Michos was a co-lead investigator on a study published in the Archives of Internal Medicine which found that inadequate levels of vitamin D could lead to a 26 percent increased risk of death. Michos and her colleagues came to this conclusion by analyzing data from the Third National Health and Nutrition Examination Survey and people's vitamin D levels at the time of death. She also completed another study in November where she studied if there was a correlation between changes in coronary artery calcium and levels of sex hormones. The study concluded that men who produced natural sex hormones ran a higher risk of developing atherosclerosis or hardening of the arteries. It also found that older women who produced high levels of estrogen were more likely to develop coronary artery calcium. In 2009, Michos and Blumenthal used data collected from the JUPITER trial to research how many United States patients with low-cholesterol and high-C-reactive protein would benefit from digesting statin. They gathered data generated by the National Health and Nutrition Examination Survey from 1971 to 2009 of patients who fit the JUPITER trial requirements and concluded that 6.5 million older adults would benefit. The following year, Michos introduced data collected from a 14-year study of over 8,000 white and black adults which concluded that unlike for white people, low vitamin D was not the cause for the higher rate of strokes amongst black adults.